期刊文献+

不同分子亚型乳腺癌临床特征及治疗策略研究进展 被引量:1

下载PDF
导出
摘要 乳腺癌是女性发病率最高的恶性肿瘤,是严重影响女性身心健康及生命安全的重要疾病之一。本文对上述4种乳腺癌亚型的生物学特性,治疗方法及预后进行分析与比较。
出处 《牡丹江医学院学报》 2013年第2期76-78,共3页 Journal of Mudanjiang Medical University
基金 泸州市科技计划资助项目[2012-S-36(4/14)]
关键词 亚型 乳腺癌 治疗
  • 相关文献

参考文献18

  • 1Garey LA, Perou CM,Livasy CA, et al. Race, breast cancer sub-types ,and survival in the Carolina BreastCancer Study [ J ] . JAMA,2006, 295(21) ,2492 -2502.
  • 2Rakha EA,. El -Rehhim DA,Paish C,et cd. Basal phenotype identi-fies & poor prognostic subgroup of breast cancer of clinical importance[J].Eur J Cancer,2006,42(18) :3149 - 3156.
  • 3Langerod A, 2iou H, Boi^an 0,et al. TP53 mutati<m status andgene expression prtrfiles are powerful prognostic markers of breastcanc?:[ J]. Breast Cancer Res,2007,9(3) :R30.
  • 4Sortie T, Perou CM, Tlbshirani K, et al. Gene expiesaion patterns ofbreast carcinomas distinguish tumor subclasses with clinical implica-tions[J] . Proc Natl Acad Sci USA, 2001,98(19) :10869-10874.
  • 5Hughes KS,Schnc^er LA,Beny D,? et al. Lumpectomy plus tamox-ifen widi or without iiradialion in women 70 years of age or older withearly breast cancer[J]. N Engl J Med, 2004 , 351(10):971 -977.
  • 6Fyles AW,McCready DR, Manchul LA,et al. Tamoxifen with or with-out ineast inradiation in 'women 50 years td age or old扭 with eazlybreast cancer[J]. N En^ J Med,2004^ 351(10) :963 - 970.
  • 7Fisher B,Coetantino JP,Wickerfiam DL,et al. Tamradfen for the pre-vention of breast cancer: current status of the National Surgical Adju-vant Breast and Bowel Project P - 1 study[ J]. J N^l Cancer Inst,2005 , 97(22):1652 - 62.
  • 8Howell A,Cuzick J,Baum M, et al. Results of the ATAC (Arimidex,Tamoxifen, Alone or in Combination) trial after completion of 5 years. adjuvant treatment for breast cancer [ J ]. Lancet. 2005,365(9453):60-62.
  • 9Grana G. Adjuvant aromatase inhibitor therapy for eazly breast canc-er: A review of the most recent data[ J]. J Surg Oncol ,2006,93(7 ):585 - 592.
  • 10Breast International Group ( BIG) 1-98 Collaborative Group,ThUriimann B9 Keshaviah A, Coates AS, et al. A comparison ofletrozole and tamoxifen in postmenopausal women with early breastcancer[J]. N Engl J Med. 2005 , 353 ( 26) :2747 - 2757.

二级参考文献17

  • 1PEROU C M,SORLIE T,EISEN M B,et al. Molecular portraits of human breast tumours [J]. Nature,2000,406 (6797) : 747 - 752.
  • 2GAREY L A,PEROU C M, LIVASY C A,et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study[J]. JAMA,2006,295(21 ) :2492 - 2502.
  • 3SORLIE T,PEROU C M,TIBSHIANI R,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications [ J ]. Proc Natl Acad Sci USA ,2001,98(19) : 10869 - 10874.
  • 4RAKHA E A, EI-REHIM D A, PAISH C, et al. Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance [ J ]. Cancer,2006,42: 3149 - 3156.
  • 5LANGEROD A,ZHOU H,BORGAN O,et al. TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer [J]. Breast Cancer Res, 2007,9:R30.
  • 6CLEATOR S,HELLER W,COOMBES RC. Triple-negative breast cancer:therapeutic options [J]. Lancet Oncol, 2007,8(3 ) : 235 - 244.
  • 7ONITILO A A, ENGEL J M, GREENLEE R T, et al. Breast cancer subtypes based on ER/PR and Her2 expression:comparison of clinicopathologic features and survival [J]. Clin Med Res,2009,7( 1-2):4 - 13.
  • 8JAHANZEB M. Adjuvant/rastuzumab therapy for HER2- positive breast cancer [J]. Clin Breast Cancer,2008,8 (4) :324 - 333.
  • 9LUND M J, BUTLER E N,BUMPERS H L,et al. High prevalence of triple-negative tumors in an urban cancer center[ J ]. Cancer, 2008,113 ( 3 ) : 608 - 615.
  • 10GERSON R,ALBAN F,VILLALOBOS A,et al. Recurrence and survival rates among early breast cancer cases with triple-negative immunophenotype [J]. Gac Med Mex, 2008,144( 1 ):27 - 34.

共引文献4

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部